NU7441: A multikinase and DNA-PK inhibitor combination immunomodulates melanomas, suppresses tumor progression, and enhances immunotherapies
Mek signal
These electrophilic groups react with amino acid side chains to form covalent adducts.
NU7441: A multikinase and DNA-PK inhibitor combination immunomodulates melanomas, suppresses tumor progression, and enhances immunotherapies